Filter Results

Clinical Studies

Open

  • A Phase 2, Double-Blind, Placebo-Controlled Study To Investigate The Safety And Efficacy Of Mibavademab In Adult Women With Functional Hypothalamic Amenorrhea Jacksonville, FL This study is researching an experimental drug called mibavademab (also called "study drug"). The study is focused on patients with a condition called Functional Hypothalamic Amenorrhea (FHA). FHA is a condition where a woman stops menstruating because the brain is not sending the correct hormonal signals to the ovaries, which then are not able to cycle and ovulate properly.

    The aim of the study is to see how well the study drug helps the body make the hormones necessary for ovulation and reproduction, and to assess its safety.

    The study is looking at several other research questions, including:

    * Whether the drug helps bone health
    * What side effects may happen from taking the study drug
    * How much study drug is in the blood at different times
    * Whether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects)
  • Biorepository of Human Blood for Age Related Research Jacksonville, FL

    The purpose of this biorepository study is to establish a repository for age related research.
  • Hypothalamic Amenorrhea as a Fertility Status Marker for Cardiovascular Health (ARCH) Jacksonville, FL

    The purpose of this study is to use innovative remote patient monitoring and patient reported outcomes to investigate Hypothalamic Amenorrhea (HA) specific phenotype(s) related to cardiovascular disease (CVD) (and vascular inflammation).

     
  • MenoZen VR For Menopause Symptom Management: Phase 2 Jacksonville, FL

    The purpose of this study is to evaluate the feasibility, acceptability, tolerability, and preliminary clinical efficacy of MenoZen VR for managing menopause symptoms in women.
  • The Registry of Very Early Estrogen and Anovulation: (REVEAL) Jacksonville, FL Rochester, MN

    The purpose of this study is to to build a registry of women with early estrogen loss due to FHA to understand the prevalence, racial and ethnic diversity of this condition.  

Closed for Enrollment

.